Azenta Life Science
Azenta Life Science, headquartered in the United States, is a leading provider in the life sciences industry, specialising in sample management and genomic services. Founded in 2021, the company has quickly established itself as a key player, offering innovative solutions that streamline research and development processes for biopharmaceutical and academic institutions. With a focus on biobanking, sample logistics, and genomic analysis, Azenta Life Science distinguishes itself through its advanced technology and commitment to quality. The company’s core services include automated sample storage, data management, and comprehensive genomic services, all designed to enhance efficiency and accuracy in scientific research. Recognised for its robust market position, Azenta Life Science continues to achieve significant milestones, contributing to advancements in personalised medicine and drug discovery. Its dedication to innovation and customer satisfaction solidifies its reputation as a trusted partner in the life sciences sector.
DitchCarbon Score
How does Azenta Life Science's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Azenta Life Science's score of 48 is higher than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Azenta Life Science's reported carbon emissions
In 2024, Azenta Life Sciences reported total carbon emissions of approximately 4,147,000 kg CO2e for Scope 1 and about 9,989,000 kg CO2e for Scope 2. This reflects a slight decrease in Scope 1 emissions from 4,513,000 kg CO2e in 2023 and 4,647,000 kg CO2e in 2022. For Scope 2, emissions were about 10,565,000 kg CO2e in 2023 and approximately 13,492,000 kg CO2e in 2022, indicating a trend towards reduction. Azenta has set ambitious targets to reduce its greenhouse gas emissions, committing to a 55% reduction in Scope 1 and Scope 2 emissions by 2033, using 2022 as the baseline year. This commitment is part of their long-term strategy to achieve net-zero emissions across all scopes by 2050, as recognised by the Science Based Targets initiative (SBTi). The company’s emissions data is not cascaded from any parent organisation, and all reported figures are directly attributed to Azenta, Inc. This proactive approach to climate commitments positions Azenta as a responsible player in the pharmaceuticals, biotechnology, and life sciences sector, aligning with industry standards for sustainability and environmental stewardship.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 4,647,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 13,492,000 | 00,000,000 | 0,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Azenta Life Science is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
